The diagnosis and treatment of hepatocellular carcinoma (HCC) constitute a complex and challenging clinical paradigm.
Nataliya Razumilava, MD
Advertisement
Articles by Nataliya Razumilava, MD
Advertisement
Latest Updated Articles
- Sorafenib for HCC: A Pragmatic Perspective
Published: March 17th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
2
FDA Grants Fast Track Designation to MT-125 in Glioblastoma
3
HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma
4
FDA Accepts NDA for New Nilotinib Formulation in CML
5
